Compared to the HCV-negative controls, patients with HCV-positive DLBCL had differential expression of genes that regulate innate immune response and modulate apoptotic pathways have higher proliferative index and lack BCL2 translocations. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.